Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
Not yet recruiting · NCT07780565 · Registry updated 2026-08-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Not yet recruiting | Phase 1 | 2026-08-21 | NCT07780565 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Carna Biosciences, Inc. | 2 |
| M.D. Anderson Cancer Center | 1145 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UT MD Anderson Cancer Center | Houston | United States | 204 |